Active Ingredient Crizotinib

Active Ingredient Details

What is Crizotinib?

A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER.

What is the usage for Crizotinib?

Crizotinib is used to treat certain types of lung cancer. Crizotinib works by slowing or stopping the growth of lung cancer cells. It belongs to a class of drugs known as kinase inhibitors.

How many products in the NDC database contain Crizotinib?

The NDC database has 10 products with the active ingredient Crizotinib. The following table lists all the products that have this active ingredient.

NDC Products with Crizotinib

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0251Proprietary Name: Xalkori CrizotinibCapsule, Coated PelletsOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0507Proprietary Name: Xalkori CrizotinibCapsule, Coated PelletsOralPfizer Laboratories Div Pfizer IncACTIVE
0069-1500Proprietary Name: Xalkori CrizotinibCapsule, Coated PelletsOralPfizer Laboratories Div Pfizer IncACTIVE
0069-8140Proprietary Name: Xalkori CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncACTIVE
0069-8141Proprietary Name: Xalkori CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncACTIVE
53869-2230Proprietary Name: CrizotinibCapsulePfizer Manufacturing Deutschland Gmbh (betriebsst�tte Freiburg)ACTIVE
53869-2231Proprietary Name: CrizotinibCapsulePfizer Manufacturing Deutschland Gmbh (betriebsst�tte Freiburg)ACTIVE
54893-0501Proprietary Name: CrizotinibPowderMsn Laboratories Private LimitedACTIVE
60715-1551Proprietary Name: CrizotinibPowderPfizer Ireland PharmaceuticalsACTIVE
68724-1020Proprietary Name: CrizotinibPowderPfizer Asia Manufacturing Pte LtdACTIVE
<